SEARCH

SEARCH BY CITATION

References

  • 1
    Egeberg O. Inherited antithrombin deficiency causing thrombophilia. Thromb Diath Haemorrh 1965; 13: 51630.
  • 2
    Heit JA, Armasu SM, Asmann YW, Cunningham JM, Matsumoto ME, Petterson TM, de Andrade M. A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. J Thromb Haemost 2012; 10: 152131.
  • 3
    Miyawaki Y, Suzuki A, Fujita J, Maki A, Okuyama E, Murata M, Takagi A, Murate T, Kunishima S, Sakai M, Okamoto K, Matsushita T, Naoe T, Saito H, Kojima T. Thrombosis from a prothrombin mutation conveying antithrombin resistance. N Engl J Med 2012; 366: 23906.
  • 4
    Simioni P, Tormene D, Tognin G, Gavasso S, Bulato C, Iacobelli NP, Finn JD, Spiezia L, Radu C, Arruda VR. X-linked thrombophilia with a mutant factor IX (factor IX Padua). N Engl J Med 2009; 361: 16715.
  • 5
    de la Morena-Barrio ME, Anton AI, Martinez-Martinez I, Padilla J, Minano A, Navarro-Fernandez J, Aguila S, Lopez MF, Fontcuberta J, Vicente V, Corral J. Regulatory regions of SERPINC1 gene: identification of the first mutation associated with antithrombin deficiency. Thromb Haemost 2012; 107: 4307.
  • 6
    Martinez-Martinez I, Johnson DJ, Yamasaki M, Navarro-Fernandez J, Ordonez A, Vicente V, Huntington JA, Corral J. Type II antithrombin deficiency caused by a large in-frame insertion. Structural, functional and pathological relevance. J Thromb Haemost 2012; 10: 185966.
  • 7
    McCoy AJ, Pei XY, Skinner R, Abrahams JP, Carrell RW. Structure of beta-antithrombin and the effect of glycosylation on antithrombin’s heparin affinity and activity. J Mol Biol 2003; 326: 82333.
  • 8
    Jaeken J. Congenital disorders of glycosylation (CDG): it’s (nearly) all in it. J Inherit Metab Dis 2011; 34: 8538.
  • 9
    Grünewald S, Schollen E, Van Schaftingen E, Jaeken J, Matthijs G. High residual activity of PMM2 in patients’ fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency). Am J Hum Genet 2001; 68: 34754.
  • 10
    Arnoux JB, Boddaert N, Valayannopoulos V, Romano S, Bahi-Buisson N, Desguerre I, de Keyzer Y, Munnich A, Brunelle F, Seta N, Dautzenberg MD, de Lonlay P. Risk assessment of acute vascular events in congenital disorder of glycosylation type Ia. Mol Genet Metab 2008; 93: 4449.
  • 11
    Young G, Driscoll MC. Coagulation abnormalities in the carbohydrate-deficient glycoprotein syndrome: case report and review of the literature. Am J Hematol 1999; 60: 669.
  • 12
    Van Geet C, Jaeken J, Freson K, Lenaerts T, Arnout J, Vermylen J, Hoylaerts MF. Congenital disorders of glycosylation type Ia and IIa are associated with different primary haemostatic complications. J Inherit Metab Dis 2001; 24: 47792.
  • 13
    Caspers M, Pavlova A, Driesen J, Harbrecht U, Klamroth R, Kadar J, Fischer R, Kemkes-Matthes B, Oldenburg J. Deficiencies of antithrombin, protein C and protein S – practical experience in genetic analysis of a large patient cohort. Thromb Haemost 2012; 108: 24757.